secwatch.observer — SEC 8-K summary
======================================

Issuer:     cbdMD, Inc. (YCBD)
CIK:        0001644903
Form:       8-K
Filed at:   2025-04-11T23:59:59+00:00
Accession:  0001437749-25-011788
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud

cbdMD shareholders approve automatic conversion of Series A Preferred Stock into common at 13:1
--------------------------------------------------------------------------------

- Shareholders approved automatic conversion of each Series A Preferred share into 13 common shares, eliminating $6.7M in accrued dividends and $4M annual dividend obligations.
- Seven directors elected: Bakari Sellers, William F. Raines III, Scott G. Stephen, Dr. Sybil Swift, T. Ronan Kennedy, Jeffrey Porter, Kevin Roe.
- Shareholders ratified Cherry Bekaert LLP as independent auditor for fiscal year ending Sept 30, 2025.
- Shareholders authorized reverse stock split at a ratio from 1:3 to 1:10, at Board's discretion within one year.
- CEO Ronan Kennedy stated conversion will strengthen balance sheet and enable strategic activity including M&A.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644903/000143774925011788/0001437749-25-011788-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644903/000143774925011788/ycbd20250410_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-011788

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer